Iodine seed implant plus chemotherapy for metastatic pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial studies whether placing iodine-125 radioactive seeds during a procedure, along with chemotherapy, can improve outcomes for people with pancreatic cancer that has spread to other organs. It aims to test a treatment that targets the tumor area while systemic chemotherapy works throughout the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged 18 to 80 years
- Have stage IV pancreatic ductal adenocarcinoma (pancreatic cancer that has spread) and tumors can be measured on scans
- Have not had any prior chemotherapy, radiation, or surgery
- You must be expected to live more than 6 months
- You need to be medically able to receive chemotherapy (blood counts, liver/kidney tests, and an ECG within limits)
- You must be able to safely undergo an ultrasound-guided procedure to place the iodine seeds
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, IBI343, combined with chemotherapy for people with advanced pancreatic cancer that has gotten worse after first-line treatment. It looks at whether this combination can help shrink tumors or slow cancer growth.
This trial tests a new immunotherapy for people with advanced pancreatic cancer that cannot be removed by surgery or has spread. It may be an option if you have already tried at least one previous treatment or if you have not had any treatment yet, depending on the study group.
This trial tests a new immunotherapy drug called ivonescimab combined with chemotherapy, with or without another experimental drug (AK117), for people with pancreatic cancer that has spread. The goal is to see if adding these therapies can help shrink tumors or slow the cancer's growth.
This trial tests a new immunotherapy drug (ivonescimab) combined with targeted radiation and chemotherapy for people with pancreatic cancer. The goal is to see if this combination can shrink tumors and improve outcomes.
This trial tests a treatment that places tiny radioactive seeds directly into some of your tumors, combined with your usual cancer therapy. It is for people who have 6 to 10 tumors that have spread to other parts of the body (not the brain). The goal is to see if adding this implant procedure helps control the tumors better.
This trial tests a combination of the immunotherapy drug Ivonescimab, chemotherapy (GnP), and stereotactic body radiation therapy (SBRT) for people with metastatic pancreatic cancer. It aims to see if this combo can help shrink tumors and improve outcomes.
Hear when a new Metastatic Pancreatic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.